Clinical Outcomes of Newborns Born to Pregnant Women With and Without COVID-19

Kahramanmaras Sutcu Imam University202 enrolled

Overview

A case-control trial was conducted to test the early postpartum period clinical outcomes of newborns born to pregnant women with and without COVID-19.

Study Type

OBSERVATIONAL

Enrollment

202

Conditions

Covid19 Vertical Transmission of Infectious Disease Neonatal Infection Pregnancy Related

Interventions

Reviewed clinical records and laboratory resultsDIAGNOSTIC_TEST

Retrospectively reviewed clinical records and laboratory results

Eligibility

Sex: ALLMin age: 19 YearsMax age: 45 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: Pregnant women on labor or preterm labor. Pregnant women who underwent programmed or emergence cesarean Exclusion Criteria: Those who were transferred to another hospital without or within a short period of delivery

Locations (1)

Denizli State Hospital

Denizli, Turkey (Türkiye)

Outcomes

Primary Outcomes

Vertical transmission

Determine the prevalence of COVID-19 in newborns born to pregnant women with COVID-19 with PCR from a nasopharyngeal swab.

Time frame: 48 hours after birth

Neonatal birth outcomes

Determine the neonatal outcomes of the newborn specifying the birth week of the newborn, delivery type (vaginal or cesarean), birth weight (g), APGAR scores in the first and fifth minutes after birth.

Time frame: At birth

Neonatal postnatal outcomes

Determine the prevalence of neonatal postnatal outcomes of the newborn specifying the respiratory system illness, intensive care need, oxygen need, neonatal mortality, general health status, and breastfeeding status.

Time frame: Within 48 hours after birth

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.